Trimethoprim (Novel Laboratories, Inc.)
Welcome to the PulseAid listing for the Trimethoprim drug offered from Novel Laboratories, Inc.. This Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novel Laboratories, Inc. |
NON-PROPRIETARY NAME: | Trimethoprim |
SUBSTANCE NAME: | TRIMETHOPRIM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-03-04 |
END MARKETING DATE: | 0000-00-00 |
Trimethoprim HUMAN PRESCRIPTION DRUG Details:
Item Description | Trimethoprim from Novel Laboratories, Inc. |
LABELER NAME: | Novel Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2014-03-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 40032-330_45e1464e-633e-4797-8a8b-a7916afdcba8 |
PRODUCT NDC: | 40032-330 |
APPLICATION NUMBER: | ANDA091437 |
Other TRIMETHOPRIM Pharmaceutical Manufacturers / Labelers: